Evidence map›Paper›PMID 37734937›Full record

SynthesisJournal of epidemiology and community health2023

Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials.

Marilou Kiely, Fazia Tadount, Ernest Lo, Manish Sadarangani, Shu Qin Wei, Ellen Rafferty, Caroline Quach, Shannon E MacDonald

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Journal of epidemiology and community health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Observational
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marilou KielyDepartment of Microbiology, Infectiology, immunology & Pediatrics, University of Montreal, Montreal, Quebec, Canada marilou.kiely@inspq.qc.ca.ORCID 0000-0002-0235-3630
Fazia TadountSainte-Justine Hospital Research Center, Montreal, Quebec, Canada.
Ernest LoDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
Manish SadaranganiVaccine Evaluation Center, British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Shu Qin WeiInstitut national de santé publique du Québec, Quebec, Quebec, Canada.
Ellen RaffertyUniversity of Alberta, Edmonton, Alberta, Canada.
Caroline QuachDepartment of Microbiology, Infectiology, immunology & Pediatrics, University of Montreal, Montreal, Quebec, Canada.
Shannon E MacDonaldUniversity of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-4675-4433

Funding

CIHR
6 · The paper itself

Abstract

backgroundDespite being a vaccine-preventable disease, influenza remains a major public health threat with vaccine safety concerns reducing vaccine acceptability. Immune responses to vaccines and adverse events may differ between males and females, but most studies do not report results by sex. Using data from clinical trials, we explored sex differences in adverse events following seasonal influenza vaccines.

methodsWe obtained data for phase III randomised controlled trials identified through a systematic review and clinical trials registries, and performed a two-stage meta-analysis. Risk ratios (RR) and 95% confidence intervals (95% CI) comparing solicited reactions in females

resultsThe dataset for this analysis included 34 343 adults from 18 studies (12 with individual-level data and 6 with aggregate data). There was a higher risk of injection site reactions in females compared with males for both younger and older participants, with RRs of 1.29 (95% CI 1.21 to 1.37) and 1.43 (95% CI 1.28 to 1.60), respectively. Higher risk in females was also observed for systemic reactions, with RRs of 1.25 (95% CI 1.20 to 1.31) and 1.27 (95% CI 1.20 to 1.34) for younger and older participants, respectively. We also observed elevated risks of severe reactions in females, with a higher RR in younger

conclusionThis meta-analysis suggested a higher risk of solicited reactions following influenza vaccines for females compared with males, irrespective of age and vaccine type. Transparent communication of this risk could increase the trust in vaccines and limit vaccine hesitancy. Future studies should report results stratified by sex and explore the role of gender in the occurrence of adverse events.

Indexed as

Influenza, HumanInfluenza VaccinesAdolescentAdultFemaleHumansMaleMiddle AgedRandomized Controlled Trials as TopicSeasonsSex CharacteristicsYoung AdultInfluenza VaccinesEPIDEMIOLOGYIMMUNIZATIONINFLUENZA, HUMANPUBLIC HEALTH

Identifiers

PMID37734937
PMCPMC10646905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.